Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by CytoSorbents

FDA Accepts DrugSorb-ATR De Novo Application To Reduce the Severity of CABG-Related Bleeding Due to Ticagrelor and Initiates Substantive Review
From CytoSorbents
Via GlobeNewswire
Tickers CTSO
CytoSorbents to Report Third Quarter 2024 Operating and Financial Results
From CytoSorbents
Via GlobeNewswire
Tickers CTSO
CytoSorbents Submits DrugSorb-ATR Marketing Application to U.S. FDA to Reduce the Severity of Bleeding in Heart Bypass Surgery Patients on the Blood Thinner Ticagrelor and Provides Business Update
From CytoSorbents
Via GlobeNewswire
Tickers CTSO
CytoSorbents to Present at the H.C. Wainwright 26ᵗʰ Annual Global Investment Conference
From CytoSorbents
Via GlobeNewswire
Tickers CTSO
CytoSorbents Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From CytoSorbents
Via GlobeNewswire
Tickers CTSO
CytoSorbents Reports Second Quarter 2024 Financial and Operational Results
From CytoSorbents
Via GlobeNewswire
Tickers CTSO
CytoSorbents Appoints Peter J. Mariani Chief Financial Officer
From CytoSorbents
Via GlobeNewswire
Tickers AXGN CTSO
CytoSorbents to Report Second Quarter 2024 Operating and Financial Results
From CytoSorbents
Via GlobeNewswire
Tickers ALT CTSO
CytoSorbents Announces Compliance with Nasdaq Minimum Bid Price Requirement
From CytoSorbents
Via GlobeNewswire
Tickers CTSO
CytoSorbents Unveils Newly Redesigned, Unified Company and Product Website
From CytoSorbents
Via GlobeNewswire
Tickers CTSO
CytoSorbents to Present at the Inaugural American Association of Physicians of Indian Origin (AAPI) World Health Congress
From CytoSorbents
Via GlobeNewswire
Tickers CTSO
CytoSorbents Secures $20 Million Credit Facility
From CytoSorbents
Via GlobeNewswire
Tickers CTSO
CytoSorbents Announces the Launch and Immediate Availability of the PuriFi™ Blood Pump in the European Union
From CytoSorbents
Via GlobeNewswire
Tickers CTSO
CytoSorbents Announces Regulatory Approval of CytoSorb® in Taiwan
From CytoSorbents
Via GlobeNewswire
Tickers CTSO
CytoSorbents to Host its 2024 Virtual Annual Stockholders Meeting
From CytoSorbents
Via GlobeNewswire
Tickers CTSO
CytoSorbents STAR Registry Data on Patients on Ticagrelor Undergoing CABG Surgery with CytoSorb Presented at EuroPCR 2024. Named Top Five Finalist for Best Scientific Abstract
From CytoSorbents
Via GlobeNewswire
Tickers CTSO
CytoSorbents Reports First Quarter 2024 Results
From CytoSorbents
Via GlobeNewswire
Tickers CTSO
CytoSorbents May 6, 2024 Virtual KOL and Analyst-Investor Day: STAR-T Pivotal Trial Topline Results & Real World Experience with Antithrombotic Drug Removal in Europe
From CytoSorbents
Via GlobeNewswire
Tickers CTSO
CytoSorbents to Report First Quarter 2024 Operating and Financial Results
From CytoSorbents
Via GlobeNewswire
Tickers CTSO
STAR-T Pivotal Trial Results to Be Featured as a Late-Breaking Presentation at the 2024 American Association for Thoracic Surgery Annual Meeting
From CytoSorbents
Via GlobeNewswire
Tickers CTSO
CytoSorbents Reports Fourth Quarter and Full Year 2023 Results
From CytoSorbents
Via GlobeNewswire
Tickers CTSO
CytoSorbents to Report Fiscal 2023 Operating and Financial Results
From CytoSorbents
Via GlobeNewswire
Tickers CTSO
CytoSorbents to Present at the TD Cowen 44th Annual Health Care Conference
From CytoSorbents
Via GlobeNewswire
Tickers CTSO
Groundbreaking Randomized Controlled Trial Reports Excellent Clinical Outcomes Using CytoSorb® Intraoperatively in Heart Transplant Patients
From CytoSorbents
Via GlobeNewswire
Tickers CTSO
CytoSorbents Provides Update on the STAR-T Trial and Reports Final Independent Data and Safety Monitoring Board Recommendation
From CytoSorbents
Via GlobeNewswire
Tickers CTSO
CytoSorbents Announces Closing of $10.3 Million Registered Direct Offering
From CytoSorbents
Via GlobeNewswire
Tickers CTSO
CytoSorbents Reports Third Quarter 2023 Financial and Operational Results
From CytoSorbents
Via GlobeNewswire
Tickers CTSO
CytoSorbents to Report Third Quarter 2023 Operating and Financial Results
From CytoSorbents
Via GlobeNewswire
Tickers CTSO
CytoSorbents to Present at the 8th Annual Dawson James Conference
From CytoSorbents
Via GlobeNewswire
Tickers CTSO
CytoSorbents Highlights Upcoming Presentations at EACTS 2023: Focus on Antithrombotic Removal including the 2nd Analysis of the International STAR Registry
From CytoSorbents
Via GlobeNewswire
Tickers CTSO
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.